Patents Assigned to ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD
  • Patent number: 10577309
    Abstract: Provided is a method for preparing a pregabalin intermediate 3-isobutylglutaric acid monoamide. The method comprises: 1) adding 3-isobutylglutaric acid and urea into a first organic solvent; 2) keeping warm and refluxing when heated to 100-140° C.; 3) adding water when cooled to 70-90° C.; 4) adding an ion membrane alkaline when cooled to 40-60° C., adjusting the pH to 11.0-14.0, then keeping warm at 40-60° C.; 5) when finished keeping warm, removing an organic layer; 6) adding an acid into the water layer to adjust the pH to 1.0-3.0; 7) extracting the solution acquired in step 6) by using a second organic solvent of a total volume of V, vacuum distilling 0.5-0.6 V of the organic solvent from an organic layer acquired by extraction; and 8) cooling to 0-15° C. and crystallizing to acquire 3-isobutylglutaric acid monoamide.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: March 3, 2020
    Assignees: ZHEJIANG HUAHAI PHARMACEUTICALS CO., LTD, ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD
    Inventors: Pan Guo, Musong Liu, Zengle Zhou, Wenling Zhang, Peng Wang
  • Patent number: 10538507
    Abstract: Provided is a purifying method for dabigatran etexilate free base, comprising subjecting a dabigatran etexilate free base crude product to water slurrying to obtain a crude product B; then conducting recrystallization on the crude product B with acetone and water to obtain a crude product C; and subsequently, purifying the crude product C with a mixed solvent of tetrahydrofuran and ethyl acetate, filtering and drying to obtain a dabigatran etexilate free base finished product. The purifying method of the present invention can effectively remove various impurities and is suitable for workshop production. Salts and water-soluble organic impurities are removed by purified water slurrying, impurities with a high polarity are removed by purifying with an acetone-water solution, and impurities with a low polarity are removed by purifying with a mixed solvent of tetrahydrofuran and ethyl acetate.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: January 21, 2020
    Assignees: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD.
    Inventors: Lingjie Chen, Wenling Zhang, Peng Wang
  • Publication number: 20190152894
    Abstract: Provided is a method for preparing a pregabalin intermediate 3-isobutylglutaric acid monoamide. The method comprises: 1) adding 3-isobutylglutaric acid and urea into a first organic solvent; 2) keeping warm and refluxing when heated to 100-140° C.; 3) adding water when cooled to 70-90° C.; 4) adding an ion membrane alkaline when cooled to 40-60° C., adjusting the pH to 11.0-14.0, then keeping warm at 40-60° C.; 5) when finished keeping warm, removing an organic layer; 6) adding an acid into the water layer to adjust the pH to 1.0-3.0; 7) extracting the solution acquired in step 6) by using a second organic solvent of a total volume of V, vacuum distilling 0.5-0.6 V of the organic solvent from an organic layer acquired by extraction; and 8) cooling to 0-15° C. and crystallizing to acquire 3-isobutylglutaric acid monoamide.
    Type: Application
    Filed: June 21, 2017
    Publication date: May 23, 2019
    Applicants: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD
    Inventors: Pan GUO, Musong LIU, Zengle ZHOU, Wenling ZHANG, Peng WANG